Emma Link

3.4k total citations
54 papers, 930 citations indexed

About

Emma Link is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Emma Link has authored 54 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 16 papers in Hematology. Recurrent topics in Emma Link's work include Multiple Myeloma Research and Treatments (9 papers), Colorectal and Anal Carcinomas (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Emma Link is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Colorectal and Anal Carcinomas (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Emma Link collaborates with scholars based in Australia, New Zealand and United Kingdom. Emma Link's co-authors include Rodney J. Hicks, Simon J. Harrison, Michael Michael, Fiona Day, Alexander G. Heriot, Samuel Y. Ngan, Cuong Duong, Annette Hogg, Danny Rischin and Karin Thursky and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Emma Link

51 papers receiving 917 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emma Link Australia	16	309	296	256	230	106	54	930
Terenig Terjanian United States	10	163 0.5×	490 1.7×	126 0.5×	182 0.8×	188 1.8×	30	935
Deepak Hariharan United Kingdom	11	410 1.3×	381 1.3×	221 0.9×	190 0.8×	68 0.6×	21	869
Vito Spataro Switzerland	13	215 0.7×	482 1.6×	370 1.4×	156 0.7×	65 0.6×	26	1.0k
Marina D. Kaymakcalan United States	15	165 0.5×	423 1.4×	261 1.0×	374 1.6×	35 0.3×	32	912
Diane Savarese United States	16	218 0.7×	576 1.9×	274 1.1×	526 2.3×	82 0.8×	24	1.2k
Megan Kennedy Ireland	14	202 0.7×	571 1.9×	136 0.5×	330 1.4×	51 0.5×	33	976
Soon‐Beom Kang South Korea	24	288 0.9×	312 1.1×	239 0.9×	152 0.7×	41 0.4×	62	1.5k
Yoshihiko Taniguchi Japan	19	131 0.4×	705 2.4×	146 0.6×	612 2.7×	44 0.4×	103	1.2k
Türkkan Evrensel Türkiye	20	172 0.6×	622 2.1×	274 1.1×	277 1.2×	69 0.7×	95	1.2k
Veronika Seebacher Austria	18	353 1.1×	434 1.5×	96 0.4×	220 1.0×	33 0.3×	46	1.0k

Countries citing papers authored by Emma Link

Since Specialization

Citations

This map shows the geographic impact of Emma Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Link more than expected).

Fields of papers citing papers by Emma Link

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Link. The network helps show where Emma Link may publish in the future.

Co-authorship network of co-authors of Emma Link

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Link. A scholar is included among the top collaborators of Emma Link based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Link. Emma Link is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Link, Emma, et al.. (2025). Node-positive carcinoma of the vulva treated with curative-intent radiotherapy. International Journal of Gynecological Cancer. 35(7). 101916–101916.

Shortt, Jake, Peter Galettis, Chan Y. Cheah, et al.. (2023). A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone (NMP), in relapsed or refractory multiple myeloma. Clinical Epigenetics. 15(1). 15–15. 3 indexed citations

Tan, Lavinia, Ben Tran, Jeanne Tie, et al.. (2023). A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study. Clinical Cancer Research. 29(6). 1017–1030. 35 indexed citations

Michael, Michael, Rachel Wong, Sanjeev Gill, et al.. (2023). The Ave-Rec trial: Phase II trial of PD-L1/PD-1 blockade with avelumab plus chemoradiotherapy for locally advanced resectable T3B-4/N1-2 rectal cancer—Toxicity and interim efficacy data.. Journal of Clinical Oncology. 41(16_suppl). 3616–3616. 1 indexed citations

Cabalag, Carlos S., et al.. (2021). Increased risk of diaphragmatic herniation following esophagectomy with a minimally invasive abdominal approach. Diseases of the Esophagus. 35(6). 5 indexed citations

Liu, Zheng, Jennifer Martin, Winston Liauw, et al.. (2021). Evaluation of pharmacogenomics and hepatic nuclear imaging–related covariates by population pharmacokinetic models of irinotecan and its metabolites. European Journal of Clinical Pharmacology. 78(1). 53–64. 1 indexed citations

Chua, Boon, Emma Link, Ian Kunkler, et al.. (2021). Abstract GS2-04: A randomized phase III study of radiation doses and fractionation schedules in non-low risk ductal carcinoma in situ (DCIS) of the breast (BIG 3-07/TROG 07.01). Cancer Research. 81(4_Supplement). GS2–4. 5 indexed citations

Hicks, Rodney J., Nick Pavlakis, Emma Link, et al.. (2020). The INTERNET STUDY: A phase II study of everolimus in patients with fluorodeoxyglucose (¹⁸F) positron‐emission tomography positive intermediate grade pancreatic neuroendocrine tumors. Asia-Pacific Journal of Clinical Oncology. 16(3). 150–157. 2 indexed citations

Khot, Amit, Natalie Brajanovski, Donald P. Cameron, et al.. (2019). First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study. Cancer Discovery. 9(8). 1036–1049. 132 indexed citations

10.

Moloney, Michael A., Emma Link, Danny Rischin, et al.. (2018). Feasibility of 5-fluorouracil pharmacokinetic monitoring using the My-5FU PCM™ system in a quaternary oncology centre. Cancer Chemotherapy and Pharmacology. 82(5). 865–876. 7 indexed citations

11.

Khot, Amit, Natalie Brajanovski, Donald P. Cameron, et al.. (2017). RNA Polymerase 1 Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Malignancies: Results of a Phase I First in Human Study. Blood. 130. 3835–3835. 2 indexed citations

12.

Holland, Lucy, et al.. (2015). Prevalence and Intensity of Pain and Other Physical and Psychological Symptoms in Adolescents and Young Adults Diagnosed with Cancer on Referral to a Palliative Care Service. Journal of Adolescent and Young Adult Oncology. 4(2). 70–75. 27 indexed citations

13.

Foo, Marcus, Emma Link, Trevor Leong, et al.. (2014). Impact of advancing age on treatment and outcomes in anal cancer. Acta Oncologica. 53(7). 909–916. 8 indexed citations

14.

Herbert, Kirsten, Glen Wiesner, Emma Link, et al.. (2014). Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial. Bone Marrow Transplantation. 49(8). 1056–1062. 12 indexed citations

15.

Pilgrim, Charles, Laveniya Satgunaseelan, Alan Pham, et al.. (2012). Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity. HPB. 14(5). 333–340. 9 indexed citations

16.

Gregory, D., Rodney J. Hicks, Annette Hogg, et al.. (2012). Effect of PET/CT on Management of Patients with Non–Small Cell Lung Cancer: Results of a Prospective Study with 5-Year Survival Data. Journal of Nuclear Medicine. 53(7). 1007–1015. 58 indexed citations

17.

Senthi, Sashendra, Emma Link, & Boon Chua. (2012). Cosmetic Outcome and Seroma Formation After Breast-Conserving Surgery With Intraoperative Radiation Therapy Boost for Early Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 84(2). e139–e144. 6 indexed citations

18.

Link, Emma, Trevor Leong, Alexander G. Heriot, et al.. (2011). Twenty-Five-Year Experience With Radical Chemoradiation for Anal Cancer. International Journal of Radiation Oncology*Biology*Physics. 83(2). 552–558. 67 indexed citations

19.

Day, Fiona, Emma Link, Samuel Y. Ngan, et al.. (2011). FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy. British Journal of Cancer. 105(4). 498–504. 47 indexed citations

20.

Yeung, Justin, Victor Kalff, Rodney J. Hicks, et al.. (2011). Metabolic Response of Rectal Cancer Assessed by 18-FDG PET Following Chemoradiotherapy is Prognostic for Patient Outcome. Diseases of the Colon & Rectum. 54(5). 518–525. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact